RMD Open: Rheumatic & Musculoskeletal Diseases

Editor-in-Chief: Professor Bernard Combe, CHU Lapeyronie, Montpellier, France

RMD Open is an open access peer- reviewed journal publishing high quality original research. It covers the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation.

Follow us:

@bmj_rmdopen

Why read our journal?

High quality, peer reviewed articles relevant to those involved in the field of rheumatology, including policy makers, funders, researchers, clinicians and practising specialists Reliable and high quality content selected and reviewed by a leading international editorial team

Get insight into what your peers are reading with our Most Read articles

Sign up to eAlerts: rmdopen.bmj.com

5 reasons to publish with us

Publishes papers on musculoskeletal disorders, rheumatism and connective tissue disease Stringent peer review and fast turnaround times - 22 days from acceptance to publication (median) High impact and reach - Impact Factor: 5.1; Citescore: 7.3 Highly respected international editorial team Indexed in Web of Science, MEDLINE, Scopus, PMC, Embase, DOAJ and Google Scholar

rmdopen.bmj.com

25% off APC

Topic Collection

Call for Papers RMD Open

Pre-arthritis stages of Rheumatoid Arthritis: from Pathology to Disease Prevention Guest Editors - Annette van der Helm -van Mil and Karim Raza Topics of interest include: What mechanisms, including mechanisms for breakage of tolerance operate in pre-arthritis phases RA. What pathogenic mechanisms operate at mucosal sites, lymphoid tissues, the bone marrow and synovium in individuals prior to the onset of clinically apparent arthritis. What are the differences in pathophysiology of developing ACPA-positive and ACPA-negative RA? What are the most clinically useful predictive biomarkers (including serological and imaging biomarkers)? And more

Submission Deadline: 8th April 2025

Rheumatology from BMJ Journals

Editor’s Choice: Top recommended reads Visit us at stand 2216-N and learn more about our journals! Download your free digital copy of Recommended Reads for ACR 2024 BMJ Group is delighted to be present at ACR Convergence 2024

Receive a 20% APC discount when submiting to RMD Open or Lupus Science & Medicine

Follow our journals for live coverage during the event using the hashtag #ACR24

Find out more

Learn about the benefits of publishing open access

bmj.com/company/openaccess

Author Support

Our featured tools to help you during your publication journey

Preprint service

Article Transfer Service

BMJ Author Services

Where is My Paper?

BMJ Author Hub

Discover the real- world impact of your medical research

BMJ Impact Analytics is the only tool focused on the real-world impact of research on health and social care. If you fund, publish or produce research or policy, BMJ Impact Analytics tracks where it’s cited in clinical guidance and health policy worldwide.

impactanalytics.bmj.com

In collaboration with

Your expert guide to diagnosis, prognosis, treatment and prevention. Anytime, anywhere.

Access anywhere

Earn CME points

Automatically tracking your CME/CPD activity within BMJ Best Practice makes it easier for you to keep track of your learning and saves you time preparing for appraisal.

On the ward, at home or studying, BMJ Best Practice gives you trusted clinical decision support information in an instant.

Evidence-based

All your answers, all in one app

Our rigorous and continuous evidence-based editorial processes deliver high-quality knowledge that informs clinical practice worldwide.

You’ll have fast and easy access to the latest evidence-based information to help you care for your patients, whenever and wherever you need it.

bestpractice.bmj.com

Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9

bmjgroup.com

Powered by